2O50 | Oxidoreductase | date | Dec 05, 2006 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | The Crystal Structure Of Toxoplasma Gondii Enoyl Acyl Carrie Reductase | ||||||||||||||
authors | S.P.Muench, S.T.Prigge, R.Mcleod, J.B.Rafferty, D.W.Rice | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Enoyl-Acyl Carrier Reductase Chain: A, B Fragment: Residues 103-417 Ec: 1.3.1.9 Engineered: Yes |
Organism_scientific: Toxoplasma Gondii Organism_taxid: 383379 Strain: Rh Gene: Enr Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_strain: Bl21-Codon Plus (De3) Expression_system_vector_type: Plasmid Expression_system_plasmid: Pmalc2x | ||||||||||||||
symmetry | Space Group: P 32 2 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.90 Å | ||||||||||||
ligand | MSE | enzyme | Oxidoreductase E.C.1.3.1.9 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Studies of Toxoplasma gondii and Plasmodium falciparum enoyl acyl carrier protein reductase and implications for the development of antiparasitic agents., Muench SP, Prigge ST, McLeod R, Rafferty JB, Kirisits MJ, Roberts CW, Mui EJ, Rice DW, Acta Crystallogr D Biol Crystallogr. 2007 Mar;63(Pt 3):328-38. Epub 2007, Feb 21. PMID:17327670 |
Data retrieval |
View 2O50 in 3D |
Visual 3D analysis of 2O50 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 2O50 |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |